Cargando…
Smoking cessation in inpatient psychiatry treatment facilities: A review
BACKGROUND: Tobacco-related diseases are a leading cause of death among individuals with severe mental illness (SMI), yet interventions to address tobacco cessation are rare in inpatient settings where persons with SMI are hospitalized. While cigarette smoking rates have declined in the general popu...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244912/ https://www.ncbi.nlm.nih.gov/pubmed/32467844 http://dx.doi.org/10.1016/j.abrep.2020.100255 |
_version_ | 1783537656000413696 |
---|---|
author | Kagabo, Robert Gordon, Adam J. Okuyemi, Kola |
author_facet | Kagabo, Robert Gordon, Adam J. Okuyemi, Kola |
author_sort | Kagabo, Robert |
collection | PubMed |
description | BACKGROUND: Tobacco-related diseases are a leading cause of death among individuals with severe mental illness (SMI), yet interventions to address tobacco cessation are rare in inpatient settings where persons with SMI are hospitalized. While cigarette smoking rates have declined in the general population, they remain high in persons with SMI. Inpatient settings would be a prime location to intervene on tobacco consumption among persons with SMI. The objective of this review was to examine evidence of smoking cessation interventions in psychiatric inpatient facilities. METHOD: Using narrative overview guidelines, we searched PubMed, PsycINFO, and CINAHL for smoking cessation RCT studies published between 1950 and 2018. Studies included had to have at least started in inpatient psychiatry settings. Examples of search terms included: smoking cessation in inpatient psychiatry, smoking cessation in inpatient mental health treatment facilities, and smoking cessation and mental health. RESULTS: Following the inclusion criteria, eight RCT studies were reviewed. One study was among adolescent psychiatric inpatient smokers ages 13–17, and 7 were among adult psychiatric inpatients with mean age 41 years. Treatment periods lasting 8 to 12 weeks started in inpatient settings and continued post discharge. A combination of behavioral and pharmacological interventions were used. Pharmacological interventions were nicotine replacement therapies, and at least one study used varenicline. At baseline, participants smoked an average of 18.1 cigarettes per day. CONCLUSION: Smoking cessation in inpatient psychiatry settings is rare or delayed. There is a need for more tailored treatments among this population to help them quit smoking. |
format | Online Article Text |
id | pubmed-7244912 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-72449122020-05-27 Smoking cessation in inpatient psychiatry treatment facilities: A review Kagabo, Robert Gordon, Adam J. Okuyemi, Kola Addict Behav Rep Review article BACKGROUND: Tobacco-related diseases are a leading cause of death among individuals with severe mental illness (SMI), yet interventions to address tobacco cessation are rare in inpatient settings where persons with SMI are hospitalized. While cigarette smoking rates have declined in the general population, they remain high in persons with SMI. Inpatient settings would be a prime location to intervene on tobacco consumption among persons with SMI. The objective of this review was to examine evidence of smoking cessation interventions in psychiatric inpatient facilities. METHOD: Using narrative overview guidelines, we searched PubMed, PsycINFO, and CINAHL for smoking cessation RCT studies published between 1950 and 2018. Studies included had to have at least started in inpatient psychiatry settings. Examples of search terms included: smoking cessation in inpatient psychiatry, smoking cessation in inpatient mental health treatment facilities, and smoking cessation and mental health. RESULTS: Following the inclusion criteria, eight RCT studies were reviewed. One study was among adolescent psychiatric inpatient smokers ages 13–17, and 7 were among adult psychiatric inpatients with mean age 41 years. Treatment periods lasting 8 to 12 weeks started in inpatient settings and continued post discharge. A combination of behavioral and pharmacological interventions were used. Pharmacological interventions were nicotine replacement therapies, and at least one study used varenicline. At baseline, participants smoked an average of 18.1 cigarettes per day. CONCLUSION: Smoking cessation in inpatient psychiatry settings is rare or delayed. There is a need for more tailored treatments among this population to help them quit smoking. Elsevier 2020-01-30 /pmc/articles/PMC7244912/ /pubmed/32467844 http://dx.doi.org/10.1016/j.abrep.2020.100255 Text en http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review article Kagabo, Robert Gordon, Adam J. Okuyemi, Kola Smoking cessation in inpatient psychiatry treatment facilities: A review |
title | Smoking cessation in inpatient psychiatry treatment facilities: A review |
title_full | Smoking cessation in inpatient psychiatry treatment facilities: A review |
title_fullStr | Smoking cessation in inpatient psychiatry treatment facilities: A review |
title_full_unstemmed | Smoking cessation in inpatient psychiatry treatment facilities: A review |
title_short | Smoking cessation in inpatient psychiatry treatment facilities: A review |
title_sort | smoking cessation in inpatient psychiatry treatment facilities: a review |
topic | Review article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244912/ https://www.ncbi.nlm.nih.gov/pubmed/32467844 http://dx.doi.org/10.1016/j.abrep.2020.100255 |
work_keys_str_mv | AT kagaborobert smokingcessationininpatientpsychiatrytreatmentfacilitiesareview AT gordonadamj smokingcessationininpatientpsychiatrytreatmentfacilitiesareview AT okuyemikola smokingcessationininpatientpsychiatrytreatmentfacilitiesareview |